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PERSPECTIVES
and the Cecropins) were also identified in
Drosophila3–5 after they were found to be
strongly induced at the transcriptional level
following the injection of bacteria into the
body cavity of the fly. The next challenge in
the field was then to determine the molecu-
lar mechanisms that regulate these genes in
response to microbial infection. Because
nothing was known of the steps that lead
from the recognition of microorganisms to
the expression of genes that encode anti-
bacterial peptides, my colleagues and I (in
Jules Hoffmann’s laboratory in Strasbourg,
France) called this process ‘the black box’. In
this article, I describe the experiments that
initiated the elucidation of the signalling
pathways that control the expression of
genes encoding antimicrobial peptides in
Drosophila (TIMELINE).
Strategies for opening the black box
The first clue to what was inside the black
box of antimicrobial-peptide expression
was provided by the sequences of genes
encoding several antibacterial peptides.
Their upstream regulatory regions contain
sequence motifs that are similar to the bind-
ing sites recognized by the mammalian
nuclear factor-κB (NF-κB)/REL family of
transcription factors6. Subsequently, in 1993,
the use of fly lines carrying a reporter gene
under the control of wild-type or mutated
κB-binding motifs demonstrated that these
binding sites confer the immune inducibility
of the Diptericin and Cecropin A1 genes in
Drosophila7,8, indicating that Diptericin and
Cecropin A1 are regulated by an NF-κB-like
transcription factor. On the basis of these
observations, two distinct strategies were
adopted to identify the NF-κB-like tran-
scription factor that regulates the genes
encoding antibacterial peptides. The first
strategy was to use biochemical techniques
to purify the κB-motif binding factor(s)
from extracts of Drosophila cell lines. For
this approach, the objective was to identify
the binding factor and then to work back-
wards, step by step, to identify the upstream
elements of the signalling cascade that acti-
vate the factor. This tactic was motivated by
the successful characterization of mam-
malian NF-κB-signalling pathways that use
similar strategies9. Considerable efforts were
made to use biochemical techniques to iso-
late an NF-κB-like molecule that functions in
the Drosophila immune response; however,
this approach was ultimately unsuccessful.
The second strategy for identifying a
Drosophila NF-κB-like transcription factor
that regulates immune responses was a
genetic approach, which I undertook with
colleagues in the Hoffmann laboratory. The
power of using genetic techniques to dis-
sect complex biological processes had pre-
viously been illustrated by the mutant
screens that Eric Wieschaus and Christiane
Nusslein-Volhard carried out (in Heidelberg,
Germany) to identify Drosophila genes that
regulate early embryogenesis. In the early
1990s, several research groups identified par-
allels between the establishment of the
dorsoventral axis by the Toll pathway in
Drosophila embryos (BOX 1) and the cytokine-
induced expression of several immune genes
by the interleukin-1 receptor (IL-1R)–NF-κB-
signalling cascade in mammals10–12. These
groups noted that in both pathways, a
Toll/IL-1R (TIR)-domain-containing trans-
membrane receptor — Drosophila Toll or
mammalian IL-1R (FIG. 1) — activates intra-
cellular signalling, which culminates in the
nuclear translocation of an NF-κB/NF-κB-
like transcription factor. In Drosophila, the
NF-κB-like factor regulated by the Toll path-
way during embryonic patterning is known
as Dorsal13,14, and Dorsal regulates target
genes through κB-binding motifs15–17.
A few years ago, it would have been difficult
to argue that elucidating the mechanisms
of disease resistance in the fruit fly,
Drosophila melanogaster, would provide
new insights into mammalian immunity. 
Yet the finding that the Drosophila protein
Toll mediates immune responses to fungal
infection had a pioneering role in the
identification of Toll-like receptors as
essential regulators of mammalian host
defence, and it fundamentally altered our
understanding of innate immunity. In this
Landmark article, I describe the thought
processes and the experimental steps that
defined Toll as a key regulator of Drosophila
immune responses.
Given their relatively short lifespans, it is not
obvious that insects have, or even require, a
powerful immune system for fighting micro-
bial pathogens. Nevertheless, insects are
highly resistant to microbial infection. Until
recently, however, the mechanisms behind
this resistance were poorly understood,
because insects do not have an equivalent 
of the vertebrate adaptive immune system.
An important discovery regarding insect
immunity was made in 1981, when Hans G.
Boman and associates1,2 (in Stockholm,
Sweden) characterized the inducible anti-
bacterial peptides Cecropin and Attacin from
the moth Hyalophora cecropia. Following a
septic injury, these small peptides are pro-
duced rapidly in large amounts by the insect
fat body (an analogue of the mammalian
liver) and then secreted into the haemolymph
(insect blood) where they kill invading bac-
teria. By the early 1990s, several genes encod-
ing antibacterial peptides (such as Diptericin
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Dorsal, the identification of DIF, and the Toll
overexpression studies all indicated a link
between the Toll pathway and the expression
of antimicrobial peptides, they still did not
identify the exact function of Toll in the
immune response.
There are two pathways
The initial lack of success using genetic
strategies refocused attention on the bio-
chemical approach, and it left me at an
impasse in my attempts to use genetics to
decipher the signalling pathway that regulates
the expression of antimicrobial-peptide
genes. The way out of this quandary was
revealed by two unexpected discoveries made
in the Hoffmann laboratory. The first break-
through happened in 1994, when Philippe
Bulet (a talented biochemist) and his col-
leagues carried out a differential screen to
identify Drosophila peptides that are induced
specifically by bacterial infections. In their
screen, one of the proteins that was highly
induced by bacterial infection was a peptide,
which they called DIF-30. DIF-30 did not,
however, have any antibacterial activity, and
interest in DIF-30 declined until Bulet and
colleagues (with the help of the plant pathol-
ogist Willem F. Broekaert, from Leuven,
Belgium) showed that DIF-30 has strong
inhibitory effects against various filamentous
fungi. DIF-30 was renamed Drosomycin, and
was activated by the Toll pathway in
response to bacterial infection, none of the
mutations affecting either Dorsal or the Toll
pathway significantly altered the induction
of Diptericin expression after infection22.
During this period, Tony Ip and colleagues
(in Michael Levine’s laboratory in San
Diego, United States) identified a second
Drosophila NF-κB-like gene, which they
called Dorsal-related immunity factor (Dif ).
However, they stopped studying Dif when
they realized that it was not involved in
dorsoventral patterning of the embryo.
Further studies of Dif started when Ylva
Engström (in Stockholm) pointed out a
potential link between DIF and the expres-
sion of the genes encoding antimicrobial
peptides. They showed that DIF is expressed
by the fat body, that it can bind to the κB-like
sequence motifs in the Cecropin A promoter
and that its translocation into the nucleus is
regulated by Toll23. However, because there
were no fly lines carrying a mutation in the
Dif gene, they were unable to test for DIF
function in immune responses. A clue to
how antimicrobial-peptide expression is reg-
ulated was provided eventually by Dan
Hultmark’s group (in Stockholm), when
they observed that overexpression of an
active form of Toll increased the expression
of a Cecropin A transgene in a cell-culture
assay24. However, although our studies of
The parallels between the Toll pathway
and the IL-1R pathway raised the obvious
question of whether the Toll pathway, in
addition to its role in dorsoventral polarity,
controls the expression of antibacterial pep-
tides in differentiated tissues. Furthermore,
although the genes encoding components of
the Toll pathway were initially described as
maternal-effect genes (which regulate early
embryogenesis), it was soon apparent that
these genes are also expressed in larvae and
adults18–20. With Jean Marc Reichhart and
other colleagues21 in the Hoffmann labora-
tory, we determined that the expression of
the dorsal gene is upregulated and that in fat-
body cells, the Dorsal protein translocates
rapidly to the nucleus in response to bacter-
ial infection. These results suggested that
Dorsal was the NF-κB-like factor that medi-
ated Drosophila immune responses, and they
stimulated a wave of enthusiasm for further
studies of Dorsal. The next goal was to deter-
mine whether Dorsal regulated the expres-
sion of the genes encoding antimicrobial
peptides and whether this Dorsal activity
was linked to the Toll pathway. This project
was facilitated by the numerous dorsal and
Toll mutants from the Wiechaus–Volhard
screens, which were available at the
Tübingen stock centre (Germany). The
results that I obtained, however, were frus-
trating: although, in fat-body cells, Dorsal
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binding protein; IκB, inhibitor of NF-κB; IKK, IκB kinase; IL-1R, interleukin-1 receptor; IMD, Immune deficiency; IRD5, Immune-response deficient 5; LPS, lipopolysaccharide; NF-κB,
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Drosomycin expression is nearly normal in
imd mutants, which indicated that more than
one signalling pathway regulates the expres-
sion of antimicrobial peptides and that the
expression of the genes encoding the anti-
bacterial peptide Diptericin and the antifungal
peptide Drosomycin are regulated by separate
pathways. Corbo and Levine29 published their
own work on the imd mutation one year later,
but they did not analyse Drosomycin expres-
sion in the imd mutant. The ultimate identifi-
cation of imd as a second mutation in stock
1046 was, for me, a good lesson in genetics,
and it also reminded me that science often
progresses when unexpected help and stim-
ulation is provided by potential competitors.
publication of these studies provided the first
description of an inducible antifungal pep-
tide identified in insects25. Drosomycin then
became a key molecule in my attempts to
identify immune-signalling pathways in fruit
flies (discussed later).
The second breakthrough was my seren-
dipitous discovery of the Drosophila immune
deficiency (imd ) mutation. After failing to
link Diptericin expression with mutations in
the Toll pathway, I decided to stop focusing
solely on Toll and broaden my search.
Consequently, I began to measure the level
of Diptericin expression after infection of
any fly line that carried a mutation in a gene
that could be linked to immune responses.
To my delight, I found that Diptericin
expression was significantly reduced in stock
1046 from the Bloomington Stock Center
(United States). This fly line originates from
an EMS (ethyl methane sulphonate) muta-
genesis carried out by Ellsworth Grell in
1969 and has a mutation, Black cells (Bc),
that affects Drosophila blood cells known as
a crystal cells26. Crystal cells are implicated
in the prophenoloxidase cascade, an enzy-
matic reaction that leads to the deposition
of melanin around invading pathogens and
has an important role in arthropod
immune defence27. Our first analysis indi-
cated that the Bc mutation affected Diptericin
expression because a chromosomal defi-
ciency that spanned Bc also reduced
Diptericin expression. A link between a
melanization cascade and the expression of
antibacterial peptides was an attractive con-
cept, and we were preparing a publication
on the role of Bc in Diptericin regulation
when we realized that we were on the
wrong track: first, I noticed that other fly
lines carrying mutations that reduced the
melanization reaction did not affect
Diptericin expression; and second, Michael
Levine informed Jules Hoffmann that in
their studies, the Bc mutation did not affect
Diptericin expression. So, faced with the
absence of detectable defects in the anti
microbial-peptide expression of Toll-deficient
mutants, and after hearing about my results
during a visit from Jules Hoffmann, Joe
Corbo and Michael Levine had also started
to study stock 1046 (the Bc mutant). Using
a different set of deficiencies than I had
used, they identified a deficiency spanning
the mutation that reduced Diptericin expres-
sion but not the Bc mutation, demonstrating
that these two mutations were at different
loci. Using this new information, we then
determined that the mutation that blocked
Diptericin expression actually mapped to a
locus 3.5 centimorgans from Bc, which we
called imd, and we used genetic recombina-
tion to generate an imd-mutant line that
lacked the Bc mutation28.
When published in 1995 (REF. 28), imd was
the first reported mutation to affect the
expression of genes encoding antibacterial
peptides, and its identification demonstrated
the potential of genetic approaches for
analysing immune-signalling pathways.
Interestingly, although imd-mutant flies are
perfectly viable, they are highly susceptible to
Gram-negative bacterial infection, and this
phenotype provided the first functional
evidence that antimicrobial peptides are
important for fighting infections in vivo. I also
made the crucial observation that the level of
NATURE REVIEWS | IMMUNOLOGY VOLUME 4 | JULY 2004 | 523
F O C U S  O N  T L R  S I G N A L L I N G
Box 1 | Toll and establishment of polarity in the Drosophila embryo
Semisaturating screens carried out by
Christiane Nüsslein-Volhard’s group (in
Tübingen, Germany), as well as by Trudy
Schüpbach and Eric Wieschaus (in Princeton,
United States), identified numerous
maternal-effect mutations that disrupt
embryonic polarity. Some of these mutations
affect 12 genes that are involved in
establishing dorsoventral polarity67,68. Among
these, numerous mutations in the Toll (which
means ‘cool’ in German) locus were analysed
in further detail by Kathryn V. Anderson in
Nüsslein-Volhard’s group69. In 1988 , the Toll
gene was cloned in the Anderson laboratory
(in Berkeley, United States) and shown to
encode a transmembrane receptor70. The
molecular characterization of the other
dorsoventral patterning genes, carried out by
several research groups, has defined the
components of a signalling pathway. Recently,
two additional genes, Myd88 and Serpin-27A,
which were identified initially for their
immune phenotype, were shown to function
in dorsoventral patterning71–74. The Toll
pathway is also used at later developmental
stages, including morphogenetic movement,
muscle attachment75 and haemocyte (blood
cell) proliferation76.
During oogenesis, a molecular cue localized
on the ventral side of follicle cells initiates a
proteolytic cascade in the perivitelline space
outside the fertilized embryo, which is
mediated by the proteases Gastrulation
defective, Snake and Easter. The activity of
Easter is inhibited by the serine-protease
inhibitor, Serpin-27A. This cascade results in
the ventral processing of Spätzle in a graded manner. The cleaved form of Spätzle then functions
as a ligand for Toll. Localized activation of Toll leads to the activation of an intracellular pathway
that involves the adaptors Tube and Myd88 and the kinase Pelle. The result of this activation is the
phosphorylation and degradation of the IκB orthologue Cactus. Cactus interacts with and inhibits
the transcription factor Dorsal. Degradation of Cactus allows Dorsal to enter the nucleus, where
it regulates the genes that organize dorsoventral patterning, such as twist and snail.
DD, death domain; Serpin, serine-protease inhibitor; TIR domain, Toll/interleukin-1 receptor domain.
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peptides, indicating the selective activation of
the Toll pathway34. Furthermore, Toll-deficient
flies succumb rapidly to B. bassiana infections.
This experiment demonstrates that flies
mount immune responses that are adapted to
the invading microorganism. It was also the
first demonstration, using a natural route of
infection, that showed that Toll signalling is
required to combat a true insect pathogen.
These observations — that the Toll path-
way is more responsive to Gram-positive
bacteria and fungi, whereas IMD regulates
responses to Gram-negative bacteria —
challenged the prevailing dogma that innate
immune mechanisms provide an entirely
nonspecific response to infection. On the
contrary, the separation of Toll- and IMD-
mediated responses enables the fly to mount
an immune response that is, to some extent,
adapted to the species of aggressor. The exis-
tence of a degree of specificity in innate
immune responses is not restricted to
Drosophila, and determining how infections
by distinct microorganisms shape the innate
immune responses of vertebrates is currently
the focus of intense study. When we published
the data on selective Toll and imd activation in
1997 (REF. 34), we used the term ‘adapted
immune response’, rather than ‘specific
immune response’, to indicate how Drosophila
uses several signalling pathways to discrimi-
nate between microorganisms and mount
microorganism-specific immune responses.
Our experiments on selective Toll or imd
activation also taught us that the types of
microorganism used, as well as the infec-
tion procedure (natural versus artificial
infection), influence immune responses.
Therefore, some inconsistencies in the reports
on Drosophila immunity can probably be
attributed to the way immune responses are
triggered — a common observation in
immunology. For example, I now realize that
our success in identifying the function of Toll
transgenes encoding DIF or Dorsal into this
deletion line, they demonstrated that DIF, but
not Dorsal, was the main regulator of the
expression of genes encoding antimicrobial
peptides in adult fruit flies. Subsequently, the
identification of mutations that only affected
the Dif locus confirmed this result33.
Another important finding that we made
after our return to studying Toll, was that in
contrast to imd mutants, which die after
Gram-negative bacterial infection, fruit flies
carrying mutations in the Toll pathway are
highly susceptible to fungal infection (FIG. 2).
In addition, flies that lack both IMD and Toll
fail to express any antimicrobial peptides and
are susceptible to both bacterial and fungal
infections. The marked and complementary
phenotypes of the Toll and imd mutants indi-
cated that Toll and IMD were components of
the two main signalling pathways that regu-
late both the expression of antimicrobial pep-
tides and resistance to bacterial and fungal
infection. Our demonstration of Toll function
in the antifungal immune response was pub-
lished in 1996 (REF. 30) and provided the first
evidence that Toll has an important role in
animal host defence. In this paper, we sug-
gested a basic model in which Toll and IMD
control the expression of genes encoding
antimicrobial peptides, and we extended the
parallels between the cytokine-induced activa-
tion of NF-κB and the Toll pathway, thereby
showing that the regulation of NF-κB/NF-κB-
like molecules is an ancient mechanism for
fighting infection.
An adapted innate immune response?
When it was first shown that Drosomycin
and Diptericin are not regulated by the same
signalling pathways, I wondered whether the
expression of each gene is induced in
response to different types of infection. To
test this hypothesis, the levels of Drosomycin
and Diptericin expression were compared
after infecting fruit flies with different types
of microorganism. The results were clear:
the gene encoding the antibacterial peptide,
Diptericin, was most highly induced by
Gram-negative bacteria, whereas Gram-
positive bacteria and fungi were the
strongest inducers of the gene encoding the
antifungal peptide, Drosomycin. The sim-
plest interpretation of these results is that
Toll and imd are activated differentially by
different types of microorganism. I consider
that the best experiment supporting this
interpretation was the demonstration that
flies dusted with spores of Beauveria
bassiana (a fungus that infects insects)
specifically express the antifungal peptide
Drosomycin but do not express antibacterial
Yet, little did I know how competitive and
stimulating the genetic studies of Drosophila
immunity would become.
Toll regulates the antifungal response
Freshly armed with the discovery that imd
regulates Diptericin but not Drosomycin
expression, I postulated that the Toll pathway
could be a regulator of Drosomycin. So, in my
previous experiments, I had selected the
wrong target gene! This time, by checking
the expression of a series of genes encoding
antimicrobial peptides in Toll and Toll-
pathway mutants, my colleagues and I deter-
mined that this prediction was correct: after
microbial infection, Drosomycin expression is
regulated by the Toll pathway, whereas
Diptericin expression is regulated by imd30. It
was also shown that not all of the compo-
nents of the Toll pathway that regulate
embryogenesis (BOX 1) have an immune func-
tion. For example, Easter, a serine protease
that cleaves Spätzle and activates the Toll
pathway during embryonic development31,
does not regulate Toll during immunity.
Similarly, several lines of evidence indicated
that the NF-κB-like factor Dorsal, which is
activated by the Toll pathway during develop-
ment, is not required for the expression of
antimicrobial peptides. Initially, Tony Ip and
colleagues32 (in Worcester, United States) gen-
erated a fly line carrying a small deletion that
spans both Dif and Dorsal. By re-introducing
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Figure 2 | Toll mutants are highly susceptible
to fungal infection. Toll-deficient fruit flies
(shown), but not wild-type fruit flies, succumb
rapidly to infection with the fungus Aspergillus
fumigatus. This image is reproduced with
permission from REF. 30 © (1996) Cell Press.
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Figure 1 | Structure of the Toll and IL-1
receptors. The ectodomain of Toll comprises
leucine-rich repeats (LRRs) that are flanked by
cysteine-rich motifs (known as the N- and C-
flanks). The ectodomain of the interleukin-1
receptor (IL-1R) comprises three
immunoglobulin (Ig) domains. The intracellular
Toll/IL-1R (TIR) domain of both Toll and the 
IL-1R interacts with TIR-domain-containing
adaptor proteins (for example, Drosophila
Myd88 or the mammalian MyD88) and signals
through NF-κB or NF-κB-like molecules (FIG. 3).
in the Drosophila immune response was
partly because we routinely used a mixture of
Gram-negative and Gram-positive bacteria to
infect flies, whereas other groups only used
Gram-negative bacteria. The Gram-positive
bacteria strongly activated the Toll pathway
and enabled us to discern the role of Toll in
inducing Drosomycin expression.
The Toll and IMD paradigm
All of these findings established a model of
two potentially independent pathways that
regulate the expression of the Drosophila
genes encoding antimicrobial peptides. This
model was tested rapidly when several
groups began to use the power of Drosophila
genetics to identify new factors that regulate
Drosophila immune responses. After imd,
the next gene identified to control antibacte-
rial responses was characterized in Dan
Hultmark’s laboratory (in Umea, Sweden) in
1999 (REFS 35,36). His group demonstrated
that a deletion of the Relish gene — which
encodes a third Drosophila NF-κB-like pro-
tein — produces phenotypes that are similar
to those of fruit flies carrying the imd
mutation35,36. Subsequently, several success-
ful forward genetic screens identified other
mutations that, similar to the imd and Relish
mutations, render flies highly susceptible to
Gram-negative bacterial infections37–43.
Surprisingly, none of these mutations affect
any detectable functions of the Toll pathway.
Genetic epistasis studies and molecular
analysis of gene function show that imd,
Relish and these other genes encode com-
ponents of a signalling pathway, which is
completely distinct from the Toll pathway
and is essential for combating Gram-negative
bacterial infection38,39,42,44–48 (FIG. 3).
Today, the Toll and IMD pathways have
emerged as a simple paradigm of innate
immune-response regulation in animals,
showing how two distinct signalling cascades
can modulate the expression of a complex
transcriptional programme in response to dif-
ferent pathogens (FIG. 3). This model disputes
prevailing views of innate immunity by indi-
cating the existence of specificity and the
absence of redundancy in Drosophila innate
immune responses. There was initially some
resistance to a simple genetic model of two
separate NF-κB-like signalling pathways in
fruit flies, perhaps because studies of mam-
malian NF-κB regulation (in cultured cells)
indicate intricate and convergent networks of
signalling cascades.Although it is possible that
genetic analysis has simplified our vision of
the Drosophila immunoresponsive-signalling
pathways, I suspect that complexity exists in
the capacity of these two pathways to integrate
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Figure 3 | The Toll and Imd pathways. The genes that encode antimicrobial peptides are regulated by a
balance between two signalling pathways: the Toll pathway, which is activated mainly by fungi and Gram-
positive bacteria, and the Immune deficiency (IMD) pathway, which is activated mainly by Gram-negative
bacteria. Depending on the variant of the κB-binding motif present in the promoter, the genes encoding
antimicrobial peptides are more sensitive to the Toll–DIF cascade (for example, Drosomycin), the
IMD–Relish cascade (for example, Diptericin) or are co-regulated. Toll is activated by binding to a cleaved
form of Spätzle, which is processed by proteolytic cascades that are activated by secreted recognition
molecules (such as the peptidoglycan-recognition protein PGRP-SA and Gram-negative-bacteria-binding
protein 1, GNBP1). PGRP-SA might bind to a lysine-type peptidoglycan found in Gram-positive bacteria.
Intracellular signal transduction (BOX 1) regulates the nuclear translocation of the nuclear factor-κB (NF-κB)-
like proteins DIF and Dorsal. The IMD pathway is probably triggered by an interaction between the
transmembrane receptor PGRP-LC and peptidoglycan from Gram-negative bacteria (diaminopimelate
(DAP)-type peptidoglycan). Following PGRP-LC activation, the death-domain (DD) adaptor protein, IMD, is
recruited and binds to Fadd, which interacts with the caspase DREDD (Death-related ced-3/Nedd2-like
protein). DREDD has been shown to associate with Relish (which it might cleave directly) after Relish has
been phosphorylated by the Drosophila IKK (inhibitor of NF-κB (IκB)-kinase) complex, which comprises
Immune response deficient 5 (IRD5) and Kenny (KEY). The IKK complex is itself activated by TAK1
(Transforming-growth-factor-β-activated kinase 1) (a mitogen-activated protein kinase kinase kinase) in an
IMD-dependent manner. After cleavage, the REL domain of Relish moves to the nucleus, where it regulates
the transcription of genes with immune function77,78. Vertebrate homologues are indicated in parentheses.
ANK, ankyrin-repeat domain; DED; death-effector domain; DIF, Dorsal-related immunity factor; FADD, FAS-
associated death domain; IRAK, interleukin-1-receptor-associated kinase; MyD88, myeloid differentiation
primary-response protein 88; NEMO, NF-κB essential modulator; PSH, Persephone; RIP, receptor-
interacting protein; serpin, serine-protease inhibitor; TIR domain, Toll/interleukin-1-receptor domain; TLR,
Toll-like receptor.
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TLRs, although they both have important
roles in innate immune responses that are
mediated by NF-κB/NF-κB-like molecules.
Continued value of Drosophila models
The conservation of some immune responses
in insects and mammals has produced an
exchange of results and ideas that have invigo-
rated the field of innate immunity. The discov-
ery of TLRs was a turning point in the study of
the mammalian immune system and opened
numerous avenues of research. This discovery
also validated the fruit fly as a model for
analysing immune-response pathways. One
advantage of the Drosophila model is that it
offers a different perspective on the battle
between pathogens and their hosts, and it
allows fundamental questions in immunity to
be addressed, without the added complexity of
an adaptive immune system.A second advan-
tage of the Drosophila model is illustrated by
the studies of Toll and imd that have been
described here, during which about 100,000
flies were infected. This seems reasonable when
one understands that 300–400 flies can be
infected in one hour. Clearly, such exhaustive
studies are not possible in vertebrate immunol-
ogy. Furthermore, comparing the strategies
that different species have developed to fight
microbial infection is essential if we want to
fully understand the immune system and not
become confused by its intrinsic complexity.
These comparisons, however, also need to con-
sider the varied methods that are used to study
immune responses in different species, because
different approaches can influence the models
that we build. As discussed in this Landmark,
the immune-signalling pathways in Drosophila
were elucidated as an extension of the discov-
ery of antimicrobial peptides. However, it is not
difficult to imagine that a simple screen for
mutations that caused susceptibility to infec-
tion by pathogens would also have identified
the Drosophila NF-κB-like pathways. Such a
project was technically possible several decades
ago, but at that time, fly geneticists had mostly
deserted the field of physiology and were
focusing their attention on Drosophila devel-
opment. Finally, although the black box of
antimicrobial-peptide gene expression has lost
some of its mystery, antimicrobial peptides
are only part of the large arsenal of insect
immune responses to pathogens. As a result,
the future holds the promise of many exciting
discoveries that will probably further impact
on mammalian studies.
Bruno Lemaitre is at the Centre de Génétique
Moléculaire, Centre National de la Recherche
Scientifique, F-91198 Gif-sur-Yvette, France.
e-mail: lemaitre@cgm.cnrs-gif.fr
doi:10.1038/nri1390
many external factors (nature of infectious
agents, mode of infection) and internal fac-
tors (tissue identity, physiological state) and
to transduce these variables into a complex
output (the sequential expression of many
genes with immune function) that is far from
understood.
Distinct functions for Toll and TLRs
The studies of Toll stimulated research on
Toll-like receptors (TLRs) in mammals. In
1997, the identification of a human Toll
homologue in expressed sequence tag (EST)
databases and the analysis of its function
indicated that, similar to Toll, TLRs were
linked to NF-κB signalling and were proba-
bly important regulators of immunity49.
Subsequently, a series of remarkable studies
with mutant mice clearly demonstrated that
TLRs function as recognition receptors for
many microbial and viral ligands and control
numerous aspects of both the innate and
adaptive immune responses50,51. Interestingly,
although TLRs function as direct recognition
receptors for microbial components, the
recognition of lipopolysaccharide by TLR4 is
mediated by a complex that includes CD14
and MD2, in addition to TLR4. The identifi-
cation of TLRs as receptors for microbial and
viral ligands was not predicted by studies car-
ried out in flies because Toll clearly does not
interact directly with microbial products but
is activated by an endogenous ligand, Spätzle,
during the immune response30,52. Although
the Drosophila genome encodes eight addi-
tional Toll molecules, surprisingly, none of
these has yet been shown to participate
directly in microbial sensing, and only one
(Toll-9) has been implicated in the regulation
of immune responses (using a cell-culture
assay)53–55.
In contrast to the rapid identification of
TLRs and their ligands, the Drosophila mole-
cules involved in microbial recognition
remained unknown until recently. At pre-
sent, we know that some aspects of microbial
recognition in flies are mediated by peptido-
glycan-recognition proteins (PGRPs) and
Gram-negative-bacteria-binding proteins
(GNBPs)43,56–60 — two protein families iden-
tified, initially in other insects, by their
capacity to bind microbial components61–64
(FIG. 3). Furthermore, unlike mammals, the
Drosophila immune system recognizes
Gram-negative bacteria by detecting a spe-
cific form of peptidoglycan and not by sens-
ing lipopolysaccharide65. Therefore, it seems
that insects and mammals might use different
strategies to detect microorganisms and that
functional differences exist between the
Drosophila Toll molecules and the human
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